Covered recipient · General Payments record
CHRISTOPHER A SMITH
Allopathic & Osteopathic Physicians Family Medicine Sports Medicine
General Payments · PY2022–2024
$10,763.33
- Reported across 42 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $652.17 | 36 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $209.28 | 17 |
| PFIZER INC. | $108.28 | 5 |
| Amgen Inc. | $78.26 | 3 |
| GlaxoSmithKline, LLC. | $77.83 | 3 |
| Novo Nordisk AS | $48.00 | 2 |
| Exact Sciences Corporation | $45.58 | 2 |
| Lilly USA, LLC | $36.33 | 2 |
| Astellas Pharma US Inc | $32.93 | 1 |
| Bioventus LLC | $15.68 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (36)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $8.87 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106122254 | CMS |
| ABBVIE INC. | $8.30 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106122256 | CMS |
| ABBVIE INC. | $18.87 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106122258 | CMS |
| ABBVIE INC. | $21.98 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106122260 | CMS |
| ABBVIE INC. | $18.17 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106122262 | CMS |
| ABBVIE INC. | $7.13 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106122264 | CMS |
| ABBVIE INC. | $13.12 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106122266 | CMS |
| ABBVIE INC. | $23.38 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106122268 | CMS |
| ABBVIE INC. | $11.86 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106122270 | CMS |
| ABBVIE INC. | $20.78 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106122272 | CMS |
| ABBVIE INC. | $7.36 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106122274 | CMS |
| ABBVIE INC. | $5.79 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106122276 | CMS |
| ABBVIE INC. | $10.84 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106122278 | CMS |
| ABBVIE INC. | $8.24 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106122280 | CMS |
| ABBVIE INC. | $17.21 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106122282 | CMS |
| ABBVIE INC. | $3.67 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106122284 | CMS |
| ABBVIE INC. | $3.71 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106122286 | CMS |
| Amgen Inc. | $17.35 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111711674 | CMS |
| Amgen Inc. | $32.48 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111711676 | CMS |
| Amgen Inc. | $28.43 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117386355 | CMS |
| Astellas Pharma US Inc | $32.93 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139269700 | CMS |
| Bioventus LLC | $15.68 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137449571 | CMS |
| Exact Sciences Corporation | $22.79 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114418621 | CMS |
| Exact Sciences Corporation | $22.79 | 09/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114418625 | CMS |
| GlaxoSmithKline, LLC. | $17.60 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116436411 | CMS |
| GlaxoSmithKline, LLC. | $33.33 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115878999 | CMS |
| GlaxoSmithKline, LLC. | $26.90 | 11/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116592446 | CMS |
| Lilly USA, LLC | $18.40 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136103114 | CMS |
| Lilly USA, LLC | $17.93 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136123612 | CMS |
| Novo Nordisk Inc | $30.31 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097573646 | CMS |
| Novo Nordisk Inc | $17.69 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096943163 | CMS |
| PFIZER INC. | $14.10 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131572135 | CMS |
| PFIZER INC. | $27.88 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131577370 | CMS |
| PFIZER INC. | $24.37 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131512420 | CMS |
| PFIZER INC. | $23.07 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131551002 | CMS |
| PFIZER INC. | $18.86 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131563044 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.